Global Cord Blood Corporation

4.7500.00Vol 62.95K1Y Perf 58.19%
Apr 16th, 2021 10:57 DELAYED
BID4.75 ASK4.77
Open4.75 Previous Close4.75
Pre-Market- After-Market-
 - -%  - -
Target Price
6.50 
Analyst Rating
— 0.00
Potential %
36.84 
Finscreener Ranking
★★★★★ —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★★     72.60
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★★     79.12
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★★+ —    -
Market Cap577.37M 
Earnings Rating
Buy
Price Range Ratio 52W %
90.57 
Earnings Date
24th Feb 2021

Today's Price Range

4.664.76

52W Range

2.544.98

5 Year PE Ratio Range

8.1064.80

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
1.06%
1 Month
1.71%
3 Months
20.25%
6 Months
34.18%
1 Year
58.19%
3 Years
-50.16%
5 Years
-24.48%
10 Years
35.71%

TickerPriceChg.Chg.%
CO4.750.00000.00
AAPL133.90-0.6000-0.45
GOOG2 293.71-2.9500-0.13
MSFT259.23-0.2700-0.10
XOM56.95-0.0300-0.05
WFC43.391.15002.72
JNJ160.930.54000.34
FB305.64-2.1800-0.71
GE13.49-0.0600-0.44
JPM153.731.56001.03
Financial StrengthValueIndustryS&P 500US Markets
10.10
10.30
0.00
0.00
-
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
84.80
48.90
48.90
37.00
45.01
RevenueValueIndustryS&P 500US Markets
131.24M
1.08
-0.79
8.29
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.16-
Q01 2021-0.15-
Q04 2020-0.11-
Q03 2020-0.17-
Q02 2020-0.14-
Q01 2020-0.13-
Q04 2019-0.11-
Q03 2019-0.07-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume62.95K
Shares Outstanding121.55M
Trades Count471
Dollar Volume3.36M
Avg. Volume263.90K
Avg. Weekly Volume248.62K
Avg. Monthly Volume163.53K
Avg. Quarterly Volume273.64K

Global Cord Blood Corporation (NYSE: CO) stock closed at 4.75 per share at the end of the most recent trading day (a -0.42% change compared to the prior day closing price) with a volume of 403.90K shares and market capitalization of 577.37M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 1260 people. Global Cord Blood Corporation CEO is Ting Zheng.

The one-year performance of Global Cord Blood Corporation stock is 58.19%, while year-to-date (YTD) performance is 28.03%. CO stock has a five-year performance of -24.48%. Its 52-week range is between 2.54 and 4.98, which gives CO stock a 52-week price range ratio of 90.57%

Global Cord Blood Corporation currently has a PE ratio of 8.20, a price-to-book (PB) ratio of 0.86, a price-to-sale (PS) ratio of 4.40, a price to cashflow ratio of 7.00, a PEG ratio of 2.32, a ROA of 6.39%, a ROC of 11.28% and a ROE of 11.78%. The company’s profit margin is 45.01%, its EBITDA margin is 48.90%, and its revenue ttm is $131.24 Million , which makes it $1.08 revenue per share.

Of the last four earnings reports from Global Cord Blood Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Global Cord Blood Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Global Cord Blood Corporation is (0), with a target price of $6.5, which is +36.84% compared to the current price. The earnings rating for Global Cord Blood Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Global Cord Blood Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of 20.00%.

Global Cord Blood Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 12.15, ATR14 : 0.24, CCI20 : 131.30, Chaikin Money Flow : 0.26, MACD : 0.15, Money Flow Index : 53.94, ROC : 3.49, RSI : 54.36, STOCH (14,3) : 86.49, STOCH RSI : 0.13, UO : 70.69, Williams %R : -13.51), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Global Cord Blood Corporation in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Hold
3.00

Global Cord Blood Corporation

Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.

CEO: Ting Zheng

Telephone: +852 36058180

Address: 1 Garden Road, Hong Kong , , HK

Number of employees: 1 260

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

57%43%

Bearish Bullish

47%53%

Bearish Bullish

44%56%

News

Stocktwits